Functional Peptides: Comparing Synthetic and Sequence-Engineered Antibiofilm Pharmaceutics

Area of Science:

• Microbiology
• Biochemistry
• Drug Discovery

Background:

• Biofilm formation is a microbial defense mechanism against antimicrobials, leading to challenging infections.
• Biofilm-associated infections pose a significant threat to public health, particularly those caused by multidrug-resistant (MDR) pathogens.
• Naturally occurring antimicrobial peptides (AMPs) show promise but face limitations in stability, toxicity, and potency.

Purpose of the Study:

• To critically evaluate synthetic and engineered antimicrobial peptides (AMPs) as next-generation antibiofilm agents.
• To explore design strategies, mechanisms of action, and therapeutic potential of advanced AMPs.
• To highlight emerging technologies for developing peptide-based therapeutics against biofilm-mediated antimicrobial resistance (AMR).

Main Methods:

• Review of current literature on synthetic and engineered AMPs.
• Analysis of design approaches including rational modification, hybridization, and computational design.
• Evaluation of AI-guided optimization and multifunctional peptide platforms.

Main Results:

• Synthetic AMPs offer structural advantages like simplicity, modifiability, and stability for disrupting biofilms and bacterial membranes.
• Engineered AMPs utilize sequence modification and computational design to enhance selectivity and targeting.
• Emerging technologies like AI are accelerating the optimization of peptide therapeutics.

Conclusions:

• Synthetic and engineered AMPs represent a promising therapeutic avenue to combat biofilm infections and MDR pathogens.
• These advanced peptides can overcome the limitations of natural AMPs, offering improved stability and efficacy.
• Further development of peptide-based therapeutics, aided by AI, is crucial for addressing the growing challenge of AMR.